# Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers

> **NCT05821387** · PHASE1 · COMPLETED · sponsor: **Quantum Biopharma** · enrollment: 40 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Lucid-21-302
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05821387
- **Lead sponsor:** Quantum Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-22
- **Primary completion:** 2023-07-29
- **Final completion:** 2023-07-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05821387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05821387, "Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05821387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*